# Topical Bimatoprost Solution 0.03%in Stable Vitiligo

> **NCT01202513** · PHASE4 · WITHDRAWN · sponsor: **Gian Sagar Medical College and Hospital** · enrollment: 20 (actual)

## Conditions studied

- Vitiligo
- Repigmentation

## Interventions

- **DRUG:** Bimatoprost 0.03% topical ophthalmic solution

## Key facts

- **NCT ID:** NCT01202513
- **Lead sponsor:** Gian Sagar Medical College and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-08
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** regulatory reasons
- **Last updated:** 2011-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01202513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01202513, "Topical Bimatoprost Solution 0.03%in Stable Vitiligo". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01202513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*